We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: More Pharmaceutical Industry Consolidation: Thinning Out the Middle
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > More Pharmaceutical Industry Consolidation: Thinning Out the Middle
Business

More Pharmaceutical Industry Consolidation: Thinning Out the Middle

David Avitabile
David Avitabile
Share
2 Min Read
SHARE

Pills_and_tablets-439975-editedSo far this year there has been a lot in the news about M&A activity within the pharmaceutical industry, and lately the coverage seems to be about what’s happening with mid-tier companies, or specialty pharmaceutical companies. These companies are by no means small, but they aren’t on the same level as the top 10 global pharmaceutical companies.

Pills_and_tablets-439975-editedSo far this year there has been a lot in the news about M&A activity within the pharmaceutical industry, and lately the coverage seems to be about what’s happening with mid-tier companies, or specialty pharmaceutical companies. These companies are by no means small, but they aren’t on the same level as the top 10 global pharmaceutical companies. And they tend to be focused in markets where they have particular strengths.

Most recently, I’ve been reading a lot about two acquisitions; Actavis’ $66 billion buyout of Allergan, and Valeant’s recent bid to buy Salix Pharmaceuticals for more than $10.4 billion. These are sizable deals for both companies, each of which has ambitions to break into the top 10 list of global integrated pharmaceutical companies, joining the likes of Pfizer, AstraZeneca, GSK and the rest.

It will be interesting to see, over the long term, how this consolidation works out for both companies, and the industry as a whole. I would argue that for many of the top global pharmaceutical companies, looking back over the past 20 years, consolidation hasn’t been all that great. Not for R&D productivity, not for profitability, and certainly not for jobs in the industry.

More Read

Enhancing Cultural Competency In Healthcare Settings
Enhancing Cultural Competency In Healthcare Settings
A Healthcare Data Pro’s Innovation Wish List
Did We Learn the Secret to Fixing Healthcare in Kindergarten?
Avoid Hospital Stays by Taking Care of Yourself
The Art of Strategic Communications Planning and Content Marketing

As in all things, only time will tell.

TAGGED:pharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

hospital marketing job
BusinessFinanceHospital Administration

How to Protect Your Hospital Marketing Job and Career

September 19, 2014
Image
Business

New WellPoint Plan Increases Healthcare Consumer’s Level of “Skin in the Game”

July 10, 2013

FDA Approves Oral Hepatitis C Virus Inhibitor

May 14, 2011
bundled payments
BusinessFinance

Variations in Post-Acute Care Spending

May 19, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?